Tenaya Therapeutics Inc (TNYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||
| Net Income | -26,231 | N/A | N/A |
| Depreciation Amortization | 1,989 | N/A | N/A |
| Accounts payable and accrued liabilities | 397 | N/A | N/A |
| Other Working Capital | -250 | N/A | N/A |
| Other Operating Activity | -1 | 0 | 0 |
| Operating Cash Flow | $-24,096 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||
| Change In Deposits | -2,657 | N/A | N/A |
| PPE Investments | -2,926 | N/A | N/A |
| Investing Cash Flow | $-5,583 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||
| Common Stock Issued | 68 | N/A | N/A |
| Common Stock Repurchased | -3 | N/A | N/A |
| Other Financing Activity | 30,446 | 0 | 0 |
| Financing Cash Flow | $30,511 | $N/A | $N/A |
| Beginning Cash Position | 23,439 | N/A | N/A |
| End Cash Position | 24,271 | N/A | N/A |
| Net Cash Flow | $832 | $N/A | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -24,096 | N/A | N/A |
| Capital Expenditure | -2,926 | N/A | N/A |
| Free Cash Flow | -27,022 | 0 | 0 |